Xylo Bio
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$9.1M
Company Overview
Xylo Bio is a biotechnology company that develops targeted neuroplastogen therapies designed to rewire neural circuits and restore brain function for patients with psychiatric and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xylo Bio Comparables
Compare Xylo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 89% | |
| Gilgamesh Pharmaceuticals | 88% | |
| Kasvu Therapeutics | 86% | |
Xylo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Seed | Jun 3, 2024 | ||||
| Seed | Oct 1, 2022 | ||||
| Accelerator | Oct 1, 2021 |
Key People
Founding team and executive leadership
Xylo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startmate | Accelerator |
| Main Sequence Ventures | Seed |
| Gaingels | Seed |
| Lionheart Ventures | Seed |
| Negev Capital | Seed |
| Mystic Ventures | Seed |
| Palo Santo | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 135% MoM, reaching 8.6K.
- Oct 1, 2025
Planning Phase I trials for neurotherapeutics with TGA and FDA.
Xylo Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xylo Bio's valuation, stock price, and market status.